XORTX Therapeutics Inc.

XRTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.86

-$0.09 (-4.62%)

At close: Sep 22, 2026, 4:00 PM ET

$1.75

-$0.11 (-5.91%)

After-hours: Sep 22, 2026, 7:35 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.62%

(1D)

Rating

Updated: Sep 8, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $517.99K

1D Range

1.78 1.93

52W Range

1.59 7.05

Valuation (TTM)

PE -0.03

PB 0.10

EV/EBITDA 0.12

Valuation (NTM)

Forward PE 0.14

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -349.1%

SBC Adj. FCF Yield -352.3%

SBC Impact -0.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -78.7% | 20.2%

FCF 3Y | 5Y 40.9% | 38.8%

Returns

ROA -59.7%

ROE -127.0%

ROIC -70.3%

Financial Health

Net Cash

$992.85K

Current Ratio 3.59

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insul...

Sector Healthcare

Industry Biotechnology

Employees 2

IPO Date Sep 22, 2021

Website www.xortx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.